Full View

SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19

P Chen, A Nirula, B Heller, RL Gottlieb… - … England Journal of …, 2021 - Mass Medical Soc
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and …
被引用次数：1438 相关文章

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

P Chen, A Nirula, B Heller… - The New England …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and …
[HTML] sld.cu

[HTML][HTML] SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

P Chen, A Nirula, B Heller, RL Gottlieb… - New England Journal …, 2020 - covid19.sld.cu
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and …

SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19

P Chen, A Nirula, B Heller… - New England …, 2021 - scholars.northwestern.edu
BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and …

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.

P Chen, A Nirula, B Heller, RL Gottlieb… - The New England …, 2020 - europepmc.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and …

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

P Chen, A Nirula, B Heller, RL Gottlieb… - New England Journal …, 2021 - cir.nii.ac.jp
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

P Chen, RL Gottlieb, J Boscia - vinculo.semergen.es
Antecedentes: se ha hipotetizado, y así se ha demostrado en estudios animales, que el
empleo de anticuerpos monoclonales que neutralizan al SARS-CoV-2 serían capaces de …
[HTML] nih.gov

[HTML][HTML] SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

P Chen, A Nirula, B Heller, RL Gottlieb, J Boscia… - The New England … - ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and …

SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with COVID-19.

P Chen, A Nirula, B Heller, RL Gottlieb, J Boscia… - 2020 - cabidigitallibrary.org
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and …

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

P Chen, A Nirula, B Heller… - The New England …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and …